Chemotherapeutic Drug Resistance Associated with Differential miRNA Expression of miR-375 and miR-27 among Oral...

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Non-coding microRNAs (miRNAs) are implicated in oral cancer progression and response to chemotherapy.
• Specific miRNAs, including miR-21, miR-27, miR-145, miR-155, miR-365, miR-375, and miR-494, are potential regulators of chemotherapeutic responsiveness.

Purpose of the Study:

• To investigate the correlation between specific miRNAs and oral cancer responsiveness to Paclitaxel, Cisplatin, and Fluorouracil (5FU).
• To identify potential miRNA biomarkers for predicting chemotherapy outcomes in oral squamous cell carcinoma.

Main Methods:

• Utilized commercially available oral squamous cell carcinoma cell lines (SCC4, SCC9, SCC15, SCC25, CAL27) with varying chemosensitivity.
• Assessed miRNA expression profiles (miR-375, miR-27) and correlated them with drug resistance.
• Investigated downstream molecular targets, including Rearranged L-myc fusion (RLF), Centriolar protein B (POC1), and Nucleophosmin 1 (NPM1).

Main Results:

• SCC9 and SCC25 cell lines exhibited the highest resistance to Paclitaxel, Cisplatin, and 5FU.
• miR-375 expression was exclusively observed in the resistant SCC9 and SCC25 cell lines.
• Lack of miR-27 expression was also characteristic of the resistant SCC9 and SCC25 cell lines.
• miR-375 expression correlated with RLF upregulation and POC1 downregulation.
• Absence of miR-27 correlated with NPM1 expression.

Conclusions:

• Specific miRNAs, notably miR-375 and miR-27, are significantly associated with oral cancer chemoresistance.
• These miRNAs may influence oral cancer proliferation and drug resistance through regulatory pathways involving RLF, POC1, and NPM1.
• Further research into these miRNA-mediated mechanisms is crucial for developing novel therapeutic strategies for oral cancer.